Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2003
10/30/2003WO2003057837A8 Methods for using anti-muc18 antibodies
10/30/2003WO2003047421A3 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003WO2003031568A3 Intracellular signaling molecules
10/30/2003WO2003027143A3 Gene and protein relating to hepatocellular carcinoma
10/30/2003WO2003020415A3 Treatment of substrates using an electrochemical method
10/30/2003WO2003014310A3 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof
10/30/2003WO2003012051A3 Inhibitor of dna methylation
10/30/2003WO2002074788A3 TRP2 ISOFORM TRP2-6b CONTAINING HLA-A2-RESTRICTED EPITOPES
10/30/2003WO2002068674A3 Non-enzymatic large scale synthesis of rna
10/30/2003WO2002055704A3 Proteins, polynucleotides encoding them and methods of using the same
10/30/2003US20030204078 Contacting N4-acetyl-5',3'-di-O-acetyl-2'-O- methyl cytidine with Lewis acid to form 2'-)-methyladenosine nucleoside which is converted to phosphoramidite
10/30/2003US20030204077 RNA isolation reagent and methods
10/30/2003US20030204072 Comprises receptor protein tyrosine kinase (rPTK) for diagnosing and treating kidney or neurodegenerative diseases
10/30/2003US20030204054 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030204053 Comprise nucleotide sequences coding polypeptide for treating and preventing inflammation, tumors and nervous system disorders; animal models; gene therapy
10/30/2003US20030204050 Comprises polypeptide for treating arthritis, cancer, autoimmune, kidney and inflammatory disorders
10/30/2003US20030203862 An antisense compound 8 to 30 nucleobases targeted to 5' untranslated region, coding region, intron:exon junctin, intron region, exon region, translation termination codon region or 3' untranslated region of nucleic acid molecule
10/30/2003US20030203840 Nucleic acid containing at least one adenine base, a guanine base, a cytosine base, and at least thymin or uracil base and nucleic acid is atleast 12 bases in length, hybridizes to sense or antisense strand of second nucleic acid
10/30/2003US20030203462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203451 Interleukin-17 (IL-17)/G-protein coupled receptors protein for use in diagnosis and treatment of cell proliferative, bone and inflammatory disorders
10/30/2003US20030203440 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203439 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203437 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203432 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203431 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203430 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203428 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203402 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203401 Comprises nucleotide sequences coding membrane protein for diagnosing, preventing and treating cell proliferative, inflammatory or tumor disorders
10/30/2003US20030203376 Compositions, methods and kits for determining the presence of Mycoplasma genitalium in a test sample
10/30/2003US20030203359 Polyamide-oligonucleotide derivatives, their preparation and use
10/30/2003US20030202976 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003CA2482995A1 Low-cost production of peptides
10/30/2003CA2482767A1 Reagents for monitoring nuclei acid amplification and methods of using same
10/30/2003CA2482611A1 Functionalized nanoparticles and methods of use
10/30/2003CA2482460A1 Regulated ethylene sensitivity to control flower longevity in a plant
10/30/2003CA2482368A1 Cytokine receptor
10/29/2003EP1357189A2 Elicitor of the hypersensitive response in plants
10/29/2003EP1357185A1 4-[(3-methyl-2(3H)-benzothiazolyliden)methylene]-quinoline and -pyridine derivatives as reporter groups in probes for analysis of nucleic acids
10/29/2003EP1356284A2 Schizophrenia related genes
10/29/2003EP1356117A2 Polynucleotides for use as tags and tag complements, manufacture and use thereof
10/29/2003EP1356115A1 Methods for detection of chloral hydrate in dichloroacetic acid
10/29/2003EP1356109A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
10/29/2003EP1356104A2 Methods and probes for detection and/or quantification of nucleic acid sequences
10/29/2003EP1356093A2 Gene markers for lung cancer
10/29/2003EP1355942A2 Glp-1 fusion proteins
10/29/2003EP1355918A2 Recombinant protective protein from $i(streptococcus pneumoniae)
10/29/2003EP1355652A2 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders
10/29/2003EP1105404B1 Purification of oligomers using dual-end selection
10/29/2003EP0925306B1 Solid phase synthesis
10/29/2003EP0703985B1 Recombinant stratum corneum chymotryptic enzyme (scce)
10/29/2003EP0682710B1 Isolation process using immobilized proteins with specific binding capacities
10/29/2003CN1452661A Viral vectors for use in monitoring HIV drug resistance
10/29/2003CN1452656A Lipoxygenase
10/29/2003CN1451747A Medusa cystatin gene, and expression and use thereof
10/29/2003CN1451664A Rice flavamonocell hrf2 gene, recombinant vector and method for transgenic breeding plant therefor
10/29/2003CN1451663A Nucleotide specific to O-antigen of shigella dysenteriae I and Bacillus coli 0121
10/29/2003CN1451662A Nucleotide specific to O-antigen of shigella boydii I and Bacillus coli 0149
10/29/2003CN1125826C Hepatitis E virus gene sequence and its application
10/28/2003US6639125 Dull1 coding for a starch synthase and uses thereof
10/28/2003US6639062 Oligonucleotides which elicit ribonuclease for cleavage in complementary nucleic acid strand, having increased binding affinity/nuclease resistance; for medical diagnosis, gene therapy
10/28/2003US6639061 C3′-methylene hydrogen phosphonate oligomers and related compounds
10/28/2003US6639051 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
10/28/2003US6638745 Antiinflammatory agents, anticarcinogenic agents; arteriosclerosis, psoriasis; gene therapy, diagnosis; genetic engineering
10/28/2003US6638512 Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigens
10/28/2003US6638510 Recombinant plasmid and a method of controlling the effects of Yersinia pestis
10/28/2003US6638482 Stacked, reconfigurable system is provided. The stacked, reconfigurable system includes an inlet for receipt of a sample, a first chamber defined by a bottom support, an intermediate member, and a first spacer, the first chamber
10/28/2003CA2153898C Method for generating single-stranded dna molecules
10/26/2003CA2425886A1 Root-specific conifer gene promoter and its use
10/23/2003WO2003087765A2 System for tracing animal products
10/23/2003WO2003087389A2 Biologic modulations with nanoparticles
10/23/2003WO2003087368A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003WO2003087367A2 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003WO2003087336A2 Estrogen receptor alpha regulated gene expression, related assays and therapeutics
10/23/2003WO2003087323A2 Biologic modulations with nanoparticles
10/23/2003WO2003087166A2 Photoactivatable silane compounds and methods for their synthesis and use
10/23/2003WO2003087149A2 Bacillus licheniformis mutant host cell
10/23/2003WO2003087134A2 G-protein coupled receptor ligands and methods
10/23/2003WO2003087115A2 Oligomeric compounds having modified phosphate groups
10/23/2003WO2003087021A2 Nanoparticle delivery systems and methods of use thereof
10/23/2003WO2003086473A1 Mycoplasma polypeptides
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003050242A3 Dna amplification and sequencing using dna molecules generated by random fragmentation
10/23/2003WO2003000922A3 Chimeric immunomodulatory compounds and methods of using the same
10/23/2003WO2002079479A3 Motor proteins and methods for their use
10/23/2003WO2002077197A3 Methods for diagnosing and monitoring malignancies by screening gene copy numbers
10/23/2003WO2002044321A3 Rna interference mediating small rna molecules
10/23/2003US20030199675 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199674 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/23/2003US20030199467 Antisense modulation of human Rho family gene expression
10/23/2003US20030199466 For modulating an immune response
10/23/2003US20030199463 For therapy of cardiovascular disease, fibrotic disease
10/23/2003US20030199437 Identification, isolation and recombinant production of novel DNA; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules; fused heterologous polypeptide sequences, binding antibodies; anticarcinogenic
10/23/2003US20030199436 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199435 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199067 Growth arrest homeobox gene
10/23/2003US20030199065 Coating a solution composed of a solvent and a non-ionic surfactant having hydrophilic-lipophilic balance number < 5 on surface, drying the surface to remove solvent and thereby bring surfactant into direct contact with hydrophobic polymer
10/23/2003US20030199064 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199063 PRO polypeptides; fused to heterologous polypeptide sequences
1 ... 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 ... 899